Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.64 |
| ▸ | IDE | P14735 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HTR6 | P50406 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | CA4 | P22748 | 4/20 | 0.43 |
| ▸ | CA6 | P23280 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8320176 | 0.83 | MEN1 (0.56) | G6PDIDEALDH1A1PKMGAA | |
| SCHEMBL1368132 | 0.82 | G6PD (0.55) | G6PDIDEALDH1A1GAAMAPT | |
| SCHEMBL2908276 | 0.82 | G6PD (0.60) | G6PDIDEALDH1A1PKMGAA | |
| SCHEMBL4639254 | 0.82 | G6PD (0.60) | G6PDIDEALDH1A1PKMGAA | |
| SCHEMBL1371001 | 0.80 | G6PD (0.53) | G6PDIDEPKMGAAMAPT | |
| SCHEMBL1371008 | 0.80 | G6PD (0.53) | G6PDIDEALDH1A1CA12CA1 | |
| SCHEMBL1370002 | 0.80 | LMNA (0.55) | G6PDIDEALDH1A1PKMMAPT | |
| SCHEMBL6932811 | 0.80 | G6PD (0.58) | G6PDIDEALDH1A1PKMGAA | |
| SCHEMBL303829 | 0.80 | CA1 (0.68) | G6PDIDEALDH1A1MAPTLMNA | |
| SCHEMBL221279 | 0.80 | CA1 (0.68) | G6PDIDEALDH1A1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795340-B2 | Compositon sensitive to UV-C radiation and UV-C sterilization or disinfection dosimeter | TERRAGENE S.A. (AR) | 2023-10-24 | — | — | US | claimed |
| EP-3964554-A1 | COMPOSITON SENSITIVE TO UV-C RADIATION AND UV-C STERILIZATION OR DISINFECTION DOSIMETER | Terragene LLC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-1828210-A1 | CHEMICAL COMPOSITIONS FOR AUTHENTICATABLE POLYMERS AND ARTICLES, AND AUTHENTICATION METHODS THEREOF | General Electric Company (US) | 2007-09-05 | — | — | EP | claimed |
| US-7230113-B2 | Chemical compositions for authenticatable polymers and articles, and authentication methods thereof | GENERAL ELECTRIC COMPANY (US) | 2007-06-12 | — | — | US | claimed |
| WO-2006065541-A1 | CHEMICAL COMPOSITIONS FOR AUTHENTICATABLE POLYMERS AND ARTICLES, AND AUTHENTICATION METHODS THEREOF | GENERAL ELECTRIC COMPANY (US) | 2006-06-22 | — | — | WO | claimed |
| US-20060135658-A1 | Chemical compositions for authenticatable polymers and articles, and authentication methods thereof | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2006-06-22 | — | — | US | claimed |
| EP-4702017-A1 | SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd (KY) | 2026-03-04 | — | — | EP | disclosed |
| US-20250041319-A1 | BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | RIBOSCIENCE LLC | 2025-02-06 | — | — | US | disclosed |
| US-20240343728-A1 | COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. | 2024-10-17 | — | — | US | disclosed |
| US-12029744-B2 | Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors | RIBOSCIENCE LLC (US) | 2024-07-09 | — | — | US | disclosed |
| CN-118159534-A | Compounds that inhibit PI3K isoform alpha and methods for treating cancer | 蝎子疗法股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| EP-4363414-A1 | COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER | Scorpion Therapeutics, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| CN-113166156-B | Tyrosine kinase inhibitors, compositions and methods | 贝达药业股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| US-4018790-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-4011341-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-4008225-A | Process for the manufacture of bis-azomethine metal complex colorants | CIBA-GEIGY CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-4002640-A | ANTIFUNGAL AGENTS | SYNTEX (U.S.A.) INC. (US) | 1977-01-11 | — | — | US | disclosed |
| US-4000135-A | IRON TETRAAZANNULENES AS CATALYSTS | BASF AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3963708-A | Bis-azomethine metal complex colorants from hydroxycoumarin derivatives or hydroxychromone derivatives | CIBA-GEIGY CORPORATION (US) | 1976-06-15 | — | — | US | disclosed |
| US-3939194-A | Bis-2-azomethine pigments, process for their manufacture and their use | CIBA-GEIGY CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135658-A1 | Chemical compositions for authenticatable polymers and articles, and authentication methods thereof | H1-4, BICRA, PBRM1 | G6PD 4374/4885IDE 4204/4885ALDH1A1 2243/4885 |
| US-20240343728-A1 | COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER | PIK3CA, PIK3CD, PIK3CG | G6PD 256/4885IDE 648/4885ALDH1A1 1133/4885 |
| US-20250041319-A1 | BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | ENPP1, ENPP3, SMPD1 | G6PD 84/4885IDE 630/4885ALDH1A1 874/4885 |
| US-12029744-B2 | Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors | ENPP1, ENPP3, SMPD1 | G6PD 82/4885IDE 635/4885ALDH1A1 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.